Jonas Center Cellular Therapy Symposium

Chicago, IL US
September 20, 2024


Experience the future of medicine firsthand at the forefront of cellular therapy!
Immerse yourself in groundbreaking advancements in adoptive immunotherapy that are revolutionizing the treatment landscape for hematologic malignancies and beyond.
Join us as we convene esteemed national experts in a forum for collaboration and scientific discourse. Together, we'll delve into basic science and translational research, unlocking the potential of cellular therapeutics for hematologic malignancies, solid tumors, and non-oncologic conditions.
This symposium isn't just about dialogue—it's about shaping the future of medicine. Be part of a transformative journey that transcends boundaries, fosters interdisciplinary partnerships, and propels us closer to the ultimate goal: enhancing patient lives through the power of cellular therapy.

NEW SEPTEMBER 19 SATELLITE SYMPOSIUM! Dive deep into the forefront of cellular therapy research, presenting your work alongside esteemed experts at our trainee-focused satellite symposium—the perfect prelude to the main program! Learn more here.
Secure your place at the forefront of medical innovation. Register now and be a catalyst for change.
Learn more about the symposium at their website!

Target Audience

This activity is designed for basic and translational researchers, hematology and medical oncology physicians and fellows, immunologists, and other healthcare professionals interested in tumor immunology and cellular immunotherapy.

Learning Objectives

After this activity, participants will be able to:

  • Recall current applications of CAR T-cell therapy in hematologic malignancies;
  • Identify relevant targets and new therapeutic approaches for cellular therapy in solid tumor malignancies;
  • Define the concept of epitope editing and how it may facilitate the broader application of cellular therapy treatments;
  • State current advances in cellular therapy engineering including in vivo transduction and through the use of nanoparticles;
  • Describe current approaches and challenges using cellular therapy in patients with solid tumor malignancies;
  • List some of the mechanisms of relapse and resistance to cellular therapy;
  • Discuss current strategies using cellular therapy for the treatment of viral infections and associated conditions;
  • Evaluate strategies to overcome resistance to cellular therapy treatment approaches;
  • Assess the clinical applicability of new therapeutic strategies in cellular therapy research.
Additional information
ACGME/ABMS Core Competencies: 
Medical Knowledge
Practice-based Learning and Improvement
Systems-based Practice
For more information, please contact:
CME Coordinator Contact Name: 
Meeting Achievements
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
PDF icon Symposium Postcard5.15 MB
PDF icon Symposium Brochure6.15 MB
Available credit: 
  • 7.00 AMA PRA Category 1 Credit™
  • 7.00 Participation
Event starts: 
09/20/2024 - 8:00am
Event ends: 
09/20/2024 - 6:00pm
Activity opens: 
Activity expires: 
8:00 - 8:30 AMRegistration, Exhibit, & Breakfast
8:30 - 8:40 AMWelcome and Introductions
Peter Riedell, MD
University of Chicago
 Cellular Therapy in Solid Tumors
Faculty Moderator: Jeffrey Ward, MD, PhD
8:40 – 8:45 AMIntroduction to Session
Jeffrey Ward, MD, PhD
Washington University in St. Louis
8:45 – 9:15 AMUnmasking Hidden Targets for Adoptive T-Cell Immunotherapy of Ovarian Cancer
Kunle Odunsi, MD, PhD
University of Chicago
9:15 – 9:45 AMIL13RA2-directed CAR T cells for pediatric brain tumors
Leo Wang, MD, PhD
City of Hope National Medical Center
 Janet Rowley Lecture
Faculty moderator: John DiPersio, MD, PhD
9:45 - 9:50 AMPresentation of Janet Rowley Award
John DiPersio, MD, PhD
Washington University in St. Louis
9:50 - 10:30 AMJanet Rowley Lecture: Avoiding Alloreactive T-cells to Enable Off-the-Shelf Therapy for Lymphoma
Cliona M. Rooney, PhD
Baylor College of Medicine
10:30 - 10:50 AMBREAK
 Overcoming Resistance and Relapse to Cellular Therapy
Faculty Moderator: Nathan Singh, MD, MS
10:50 – 10:55 AMIntroduction to Session
Nathan Singh, MD, MS
Washington University in St. Louis
10:55 - 11:25 AMGenetic and Pharmacologic Interventions to Improve CAR T-cell Persistence and Function in Pre-clinical Lymphoma Models
Justin Kline, MD
University of Chicago
11:25 - 11:55 AMCuring Cancer with CR T-cells: It’s a team effort
Joseph Melenhorst, PhD
Cleveland Clinic Lerner College of Medicine
11:55 - 1:00 PMLUNCH
 Jonas Memorial Lecture
Faculty Moderator: Michael Bishop, MD
1:00 - 1:05 PMPresentation of Jonas Memorial Award
Michael Bishop, MD
University of Chicago
1:05 - 1:45 PMJonas Memorial Lecture: Molecular Cell Shielding – A Therapeutic Platform Approach for Hematologic Diseases
Lukas Jeker, MD, PhD
Basel University Hospital and the University of Basel
 Advances in Cellular Therapy Engineering
Faculty Moderator: James LaBelle, MD, PhD
1:45 - 1:50 PMIntroduction to Session
James LaBelle, MD, PhD
University of Chicago
1:50 - 2:20 PMIn Vivo CAR T-cell generation in non-human primates and tumor-bearing humanized mice using lentiviral particles displaying a multi-domain fusion protein
Byoung Ryu, PhD
Umoja Biopharma
2:20 - 2:50 PMDelivery Technologies for mRNA and Cancer Immunotherapy
Michael Mitchell, PhD
University of Pennsylvania
2:50 - 3:10 PMBREAK
 Novel Cellular Therapies – From Bench to Bedside
Faculty Moderator: Justin Kline, MD
3:10 - 3:15 PMIntroduction to Session
Justin Kline, MD
University of Chicago
3:15 - 3:45 PMAdvancing Bispecific LV20.19 CAR T cells at the Medical College of Wisconsin
Nirav Shah, MD
Medical College of Wisconsin
3:45 – 4:15 PMCar-T Cell Therapy for T-Cell Malignancies
Armin Ghobadi, MD
Washington University in St. Louis
4:15 – 4:45 PMAdvancing Cell-Based Cancer Immunotherapy Through Stem Cell Engineering
Lili Yang, PhD
University of California, Los Angeles
4:45 - 4:50 PMClosing Remarks
Faculty Moderator: Peter Riedell, MD
4:50 – 6:00 PMCocktail Reception

*The agenda is subject to change.

David Rubenstein Forum at the University of Chicago
1201 E 60th St
Chicago, IL 60637
United States


Participants can join us in person or virtually. For questions about the program, contact Meeting Achievements via email.


The David Rubenstein Forum combines a variety of spaces, both formal and informal, large and small, calm and animated, focused and diffuse, scheduled and spontaneous. Its ten-story tower features vibrant and distinct “neighborhoods.” For example, the third and fourth floors are home to Friedman Hall, a 285-seat auditorium optimized for spoken word, including keynote speeches, invited-speaker addresses, and select performances; these floors and other neighborhoods are connected by a two-story lounge. Meeting rooms on the eighth and ninth floors feature premium furnishings, finishes, and equipment, such as the Peter May Boardroom, a tiered meeting space that seats over 70. The Rubenstein Forum’s unique position on the Midway allows for expansive views toward the campus and surrounding communities as well as downtown Chicago and Lake Michigan.


A block of rooms has been held at The Study at University of Chicago for September 19-21, 2024.

Featuring 167 rooms, including nine brand-signature Study units and a complement of premium Suites. Rooms are equipped with all the amenities the modern traveler needs—whether a scholarly guest seeking the perfect leather reading chair, a visiting executive needing an expansive work desk, or a prospective student looking for a view of the campus through floor-to-ceiling windows. All guestrooms feature comfortable feather-topped beds, Frette linens and towels, a soft leather chair and ottoman from Mitchell Gold + Bob Williams, lighting from Spain-based Marset, and modern bathrooms with C.O. Bigelow toiletries. Guests enjoy essential complimentary amenities, including wireless high-speed Internet, bottled water, newspapers, and morning coffee available through our Living Room.

The Study is located at 1227 E 60th St, Chicago, IL 60637.
$279/night (Rate does not include applicable state and local taxes.)

When calling or emailing, reference the group name: Jonas Center Cellular Therapy Symposium
Check-in time is 3:00 PM. Check-out time is 12:00 PM.

If a guest wishes to check out after the 12:00 PM check-out time, a late check-out fee may be charged to that guest's individual account. Although the hotel will attempt to accommodate the requests for late check-out, this option may not be available to all guests based on the hotel’s occupancy and housekeeping requirements.

A 24-hour cancellation policy will apply to each individual reservation. To avoid a one-night room and tax cancellation penalty, reservations must be cancelled by 3 PM CST 24 hours before the arrival date of September 21, 2023.


Complimentary valet parking will be available to participants 7:30 am-6:30 pm on the date of the symposium. Additionally, free street parking is available in the area.


Discover why Condé Nast Traveler readers voted Chicago the Best Big City in the U.S. for a historic sixth year in a row. To help plan your stay in Chicago, visit

ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office via email at
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
  Peter Riedell, MD
  Associate Professor of Medicine
  University of Chicago
  John F. DiPersio, MD, PhD
  Section Director, Cellular Therapy
  Washington University School of Medicine in St. Louis


Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Participant Credit
Other participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.

Please Note: The credit claiming process will close three months after the activity ends. Requests to claim credit after three months will be subject to additional fees.
Faculty presenting at the 2023 symposium about T cell therapy complications.

Please log in or create an account below to register!

Once logged in, select the profession type and mode of participation that best suits you and click "Register Now!". Register with the applicable discount code before September 3, 2024, for the early rate.
Profession TypeEarly
Discount Code
Virtual Discount
Physician$140JIP24$175 $105JVR24$130
Research Professional$140JIP24$175$105JVR24$130
Other Healthcare Professional$95JIO24$120$85JVO24$105
Residents & Fellows
with a verification letter
UChicago & WashU Faculty & Staff$25-$25$0-$0
CANCELLATION POLICY: If you cancel your participation in this conference, your registration fee less a 50% administrative fee will be refunded when written notification is received by August 14, 2024. No refunds will be made after August 14, 2024.

After the activity, the credit-claiming process will unlock. Return to this page and simply click on "Complete Activity" to proceed.
Please Note: The credit claiming process will close three months after the activity ends. Requests to claim credit after three months will be subject to additional fees.
Please login or create an account to proceed.